Oramed Pharmaceuticals
ORMP
ORMP
44 hedge funds and large institutions have $12.6M invested in Oramed Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 17 increasing their positions, 4 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
13% more funds holding
Funds holding: 39 → 44 (+5)
1.94% less ownership
Funds ownership: 6.15% → 4.21% (-1.9%)
Holders
44
Holding in Top 10
–
Calls
$3.92M
Puts
$2.39M
Top Buyers
| 1 | +$1.35M | |
| 2 | +$694K | |
| 3 | +$610K | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$533K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$271K |
Top Sellers
| 1 | -$2.01M | |
| 2 | -$1.58M | |
| 3 | -$254K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$230K |
| 5 |
Squarepoint
New York
|
-$129K |